• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 27 of 37
Moderna says its COVID-19 vaccine is 94.5% effective
HealthModerna says its COVID-19 vaccine is 94.5% effective
By Robert Langreth and BloombergNovember 16, 2020
Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
HealthModerna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
By Robert Langreth and BloombergNovember 12, 2020
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
NewslettersThe vaccine jolt fades, sinking global stocks—except for this one surprising sector
By Bernhard WarnerNovember 12, 2020
Cold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine
HealthCold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine
By BloombergNovember 11, 2020
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
HealthEli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By Riley Griffin and BloombergNovember 10, 2020
Creating a COVID vaccine is only half the battle
HealthCreating a COVID vaccine is only half the battle
By Sy MukherjeeNovember 9, 2020
J.P. Morgan analysts call these 25 stocks ‘short’ candidates as a COVID vaccine gets closer
FinanceJ.P. Morgan analysts call these 25 stocks ‘short’ candidates as a COVID vaccine gets closer
By Lee CliffordNovember 9, 2020
Election-2020-Market-Reaction
FinanceStocks rise on game-changing news: A new President and a possible vaccine
By Anne SradersNovember 9, 2020
Medical syringes are seen with Pfizer company logo displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
FinancePfizer’s blockbuster vaccine report flips the markets on their head—pandemic stocks sink, nearly everything else soars
By David MeyerNovember 9, 2020
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
HealthPfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By Robert Langreth, Naomi Kresge, Riley Griffin and BloombergNovember 9, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
HealthAstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
COVID vaccine science
HealthThe science behind the leading COVID vaccine candidates
By Sy MukherjeeNovember 3, 2020
Two tales of innovation from CVS and Pfizer
NewslettersTwo tales of innovation from CVS and Pfizer
By Sy MukherjeeOctober 29, 2020
Pfizer’s high-tech plan to track every dose of its experimental COVID vaccine
ConferencesPfizer’s high-tech plan to track every dose of its experimental COVID vaccine
By Sy MukherjeeOctober 27, 2020
Stocks, futures slip as even a surge of ‘beats’ fail to lift the COVID gloom
NewslettersStocks, futures slip as even a surge of ‘beats’ fail to lift the COVID gloom
By Bernhard WarnerOctober 27, 2020
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...37
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Economy
The U.S. had a national debt ‘home run’ in its grasp, says Jamie Dimon. But the government did nothing, and now its best option is crisis managementplaceholder alt text
By Fortune EditorsApril 8, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.